These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2408290

  • 1. Serotonin and schizophrenia: correlations between serotonergic activity and schizophrenic motor behavior.
    King R, Faull KF, Stahl SM, Mefford IN, Thiemann S, Barchas JD, Berger PA.
    Psychiatry Res; 1985 Mar; 14(3):235-40. PubMed ID: 2408290
    [Abstract] [Full Text] [Related]

  • 2. Platelet serotonin concentration and depressive symptoms in patients with schizophrenia.
    Peitl V, Vidrih B, Karlović Z, Getaldić B, Peitl M, Karlović D.
    Psychiatry Res; 2016 May 30; 239():105-10. PubMed ID: 27137969
    [Abstract] [Full Text] [Related]

  • 3. A comparative uptake study of serotonin, dopamine, and norepinephrine by platelets of acute schizophrenic patients.
    Rotman A, Munitz H, Modai I, Tjano S, Wijsenbeek H.
    Psychiatry Res; 1980 Dec 30; 3(3):239-46. PubMed ID: 6110216
    [Abstract] [Full Text] [Related]

  • 4. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia.
    Jakovljević M, Mück-Seler D, Pivac N, Ljubicić D, Bujas M, Dodig G.
    Biol Psychiatry; 1997 May 15; 41(10):1028-34. PubMed ID: 9129783
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.
    Jackman H, Luchins D, Meltzer HY.
    Biol Psychiatry; 1983 Aug 15; 18(8):887-902. PubMed ID: 6615945
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients.
    Joseph MH, Owen F, Baker HF, Bourne RC.
    Psychol Med; 1977 Feb 15; 7(1):159-62. PubMed ID: 859953
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. On the concentration of 5-hydroxyindoleacetic acid in schizophrenia: a meta-analysis.
    Tuckwell HC, Koziol JA.
    Psychiatry Res; 1996 Jan 31; 59(3):239-44. PubMed ID: 8930029
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia.
    Ljubicić D, Stipcević T, Pivac N, Jakovljević M, Mück-Seler D.
    J Photochem Photobiol B; 2007 Dec 14; 89(2-3):63-9. PubMed ID: 17937992
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ.
    Arch Gen Psychiatry; 1990 Jul 14; 47(7):641-8. PubMed ID: 1694425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.